The purpose of this study is to compare the safety and the effects of moderate-intensity aerobic endurance training to those of an usual physical therapy intervention on exercise capacity and quality of life in patients with amyotrophic lateral sclerosis (ALS).
Scarce evidence is available regarding aerobic exercise training of patients with ALS. Some studies using transgenic mouse models of familial ALS have shown markedly slowed disease progression, improved functional capacity, and extension of survival in animals undergoing aerobic exercise training. In humans, only one non-randomized study has shown that moderate-intensity aerobic exercise training was of little beneficial effect in a small group of patients with Kennedy disease, a rare X-linked progressive neuromuscular disease involving lower motorneurons, presenting a pathophysiological picture quite different from that of ALS. To the best of our knowledge, the safety and the effects of aerobic exercise training on functional capacity and quality of life of patients with ALS have not been systematically evaluated as yet in a randomized, controlled trial with an adequate sample size.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
40
Intensity: heart rate corresponding to 40% peak VO2. Frequency: 5 sessions/week. Duration: 5 min warm-up + 20 min training + 5 min cool-down during the 1st month; 5 min warm-up + 30 min training + 5 min cool-down during the 2nd and 3rd month
Intensity: N/A. Frequency: 5 sessions/week. Duration: 5 min warm-up + 20 min training + 5 min cool-down during the 1st month; 5 min warm-up + 30 min training + 5 min cool-down during the 2nd and 3rd month
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Veruno
Veruno, Italy
RECRUITINGChange from baseline in peak oxygen consumption (peak VO2)
Evaluate the effects of aerobic training on peak VO2, as assessed by cardiopulmonary exercise testing
Time frame: 3 months
Aerobic training safety and tolerability
Evaluate aerobic training safety and tolerability in terms of adverse events incidence and adherence to training program
Time frame: 3 months
Change from baseline in quality of life
Evaluate the effects of aerobic training on quality of life, as assessed by McGill questionary
Time frame: 3 months
Change from baseline in Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALSFRS-R) score
Evaluate the effects of aerobic training on the ALSFRS-R score
Time frame: 3 months
Change from baseline in lower limbs muscle strength
Evaluate the effects of aerobic training on isometric muscle strength of lower limbs, as assessed by isometric dynamometry
Time frame: 3 months
Change from baseline in upper and lower motor neurons function at the upper and lower limbs level
Evaluate the effects of aerobic training on upper and lower motor neurons function at the upper and lower limbs level, as determined by compound muscle action potential and neurophysiological index and motor evoked potentials
Time frame: 3 months
Change from baseline in ventilatory function
Evaluate the effects of aerobic training on ventilatory function, as assessed by spirometry and measurement of maximal inspiratory and expiratory pressures
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 months
Change from baseline in circulating inflammatory markers, growth factors and descriptors of skeletal muscle damage
Evaluate the effects of aerobic training on circulating inflammatory markers and growth factors (CRP, TNF-alfa, IL-6, Angiogenin, Angiopoietin 1 and 2, Thrombospondin, VEGF, BDNF, IGF-1) and markers of skeletal muscle damage (CPK)
Time frame: 3 months